Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Heart Care & Heart Disease Articles

Calcium Score Predicts Cardiovascular Death Risk in Type 2
Islet Transplants May Decrease Type 1 Atherosclerosis Risk
Around the Table: A Dinner Host's Responsibility With Paula Deen
Is Sex Good for Your Heart Health?
Substance in Tangerines Blocks Diabetes in Mice Fed High-Sugar, High-Fat Diets
Safflower Oil Cuts Heart Disease Risk for People With Type 2 Diabetes
Salt: Its History and Hazards
The Unique Challenges of Being a Woman With Diabetes
European Researchers Say Mediterranean Diet Lowers Risk of Metabolic Syndrome
Profiles in Type 2 Diabetes: Michael Hamman
Diabetes Health Reference Charts
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
See All Charts…
Heart Care & Heart Disease Archives
Browse the Heart Care & Heart Disease Archives
Subscribe to the Complications & Care RSS Feed
Print | Email | Share | Comments (0)

Black Box Warning For Actos and Avandia


Oct 31, 2007

The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).

To catch up on the whole Avandia hoopla, read "The Latest About Avandia and Actos", "Amid Accusatory Debate, FDA Puts Black Box Warning on Avandia and Actos", and "Updated: Analysis Associates Avandia With Greater Risk of Heart Attack".

Categories: Actos, Heart Care & Heart Disease, Pharmacy, Professional Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Oct 31, 2007

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.